- Home
- NEO vs CRTO Comparison
NEO vs CRTO Comparison
Compare NEO & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- CRTO
- Stock Information
- Founded
- NEO 2001
- CRTO 2005
- Country
- NEO United States
- CRTO France
- Employees
- NEO N/A
- CRTO N/A
- Industry
- NEO Precision Instruments
- CRTO Advertising
- Sector
- NEO Health Care
- CRTO Consumer Discretionary
- Exchange
- NEO Nasdaq
- CRTO Nasdaq
- Market Cap
- NEO 1.9B
- CRTO 2.0B
- IPO Year
- NEO 1999
- CRTO 2013
- Fundamental
- Price
- NEO $15.39
- CRTO $38.62
- Analyst Decision
- NEO Strong Buy
- CRTO Buy
- Analyst Count
- NEO 8
- CRTO 10
- Target Price
- NEO $20.25
- CRTO $51.11
- AVG Volume (30 Days)
- NEO 722.4K
- CRTO 584.1K
- Earning Date
- NEO 11-05-2024
- CRTO 10-30-2024
- Dividend Yield
- NEO N/A
- CRTO N/A
- EPS Growth
- NEO N/A
- CRTO 1182.57
- EPS
- NEO N/A
- CRTO 1.63
- Revenue
- NEO $644,118,000.00
- CRTO $1,946,556,000.00
- Revenue This Year
- NEO $12.93
- CRTO N/A
- Revenue Next Year
- NEO $9.70
- CRTO $5.96
- P/E Ratio
- NEO N/A
- CRTO $23.39
- Revenue Growth
- NEO 12.06
- CRTO N/A
- 52 Week Low
- NEO $12.77
- CRTO $23.87
- 52 Week High
- NEO $21.22
- CRTO $49.93
- Technical
- Relative Strength Index (RSI)
- NEO 56.48
- CRTO 52.72
- Support Level
- NEO $14.81
- CRTO $36.08
- Resistance Level
- NEO $16.60
- CRTO $38.50
- Average True Range (ATR)
- NEO 0.67
- CRTO 1.24
- MACD
- NEO 0.01
- CRTO 0.46
- Stochastic Oscillator
- NEO 62.77
- CRTO 95.65
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.